Literature DB >> 1348711

HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.

P J Tienari1, E Tuomilehto-Wolf, J Tuomilehto, L Peltonen.   

Abstract

In Caucasians the predisposition to Type 1 (insulin-dependent) diabetes mellitus has been shown to associate with HLA-DR3,DQw2 and DR4,DQw8 and with the presence of amino acids other than aspartic acid at position 57 on the HLA-DQ beta chain. In Finland the haplotype-specific absolute risk for developing Type 1 diabetes differs between various DR3 and DR4 positive haplotypes. The aim of our present analysis was to find out whether this variation is attributable to polymorphism at the DQ locus. As part of a nationwide prospective study including 757 serologically HLA genotyped families, we determined HLA-DQ alpha and DQ beta restriction fragment polymorphisms in 17 selected families with important susceptibility haplotypes. Additionally, the DQA1 alleles were determined from 19 haplotypes using sequence-specific oligonucleotide probes, and the DQB1 second exon was sequenced from nine haplotypes. The DR3 as well as DR4 positive haplotypes frequently found in Type 1 diabetic patients showed no variation at the HLA-DQ locus, and they were DQw2 and DQw8, respectively. The absolute risk for Type 1 diabetes for DR4,DQw8 positive haplotypes A2,Cw4,Bw35,DR4 A3,Cw3,Bw62,DR4, A24,Cw7,Bw39,DR4, A2,Cw3,Bw62, DR4, and A2,Cw1,Bw56,DR4 was 35/100,000, 130/100,000, 166/100,000, 196/100,000, and 218/100,000, respectively. The absolute risks for DR3,DQw2 positive haplotypes A1, Cw7,B8,DR3 and A2,Cw7,B8,DR3 were 68/100,000 and 103/100,000, respectively. These results provide further evidence that not only the polymorphism at the DQ locus but also other genes of the haplotypes contribute to susceptibility to Type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348711     DOI: 10.1007/bf00400926

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  New genes in the class II region of the human major histocompatibility complex.

Authors:  I M Hanson; A Poustka; J Trowsdale
Journal:  Genomics       Date:  1991-06       Impact factor: 5.736

2.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector.

Authors:  C Auffray; J W Lillie; A J Korman; J M Boss; N Fréchin; F Guillemot; J Cooper; R C Mulligan; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 5.  Molecular genetics of the human major histocompatibility complex.

Authors:  C Auffray; J L Strominger
Journal:  Adv Hum Genet       Date:  1986

6.  Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.

Authors:  K Yamagata; H Nakajima; T Hanafusa; T Noguchi; A Miyazaki; J Miyagawa; M Sada; H Amemiya; T Tanaka; N Kono
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

7.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.

Authors:  M Thomsen; J Mølvig; A Zerbib; C de Preval; M Abbal; J M Dugoujon; E Ohayon; A Svejgaard; A Cambon-Thomsen; J Nerup
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

View more
  8 in total

1.  In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.

Authors:  K A Metcalfe; G A Hitman; M J Fennessy; M I McCarthy; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  HLA-A associations with IDDM--a case of numbers?

Authors:  E Bonifacio
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

3.  Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype.

Authors:  L R Weitkamp; A J Moss; R A Lewis; W J Hall; J W MacCluer; P J Schwartz; E H Locati; D Tzivoni; G M Vincent; J L Robinson
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

4.  The emerging global epidemic of type 1 diabetes.

Authors:  Jaakko Tuomilehto
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

5.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

6.  Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region.

Authors:  E Tuomilehto-Wolf; J Tuomilehto; G A Hitman; A Nissinen; J Stengård; J Pekkanen; P Kivinen; E Kaarsalo; M J Karvonen
Journal:  BMJ       Date:  1993-07-17

7.  A new marker in the HLA class I region is associated with the age at onset of IDDM.

Authors:  A G Demaine; M L Hibberd; D Mangles; B A Millward
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

8.  Full likelihood analysis of genetic risk with variable age at onset disease--combining population-based registry data and demographic information.

Authors:  Janne Pitkäniemi; Sirkka-Liisa Varvio; Jukka Corander; Nella Lehti; Jukka Partanen; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Andrew Thomas; Elja Arjas
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.